CORRECTSEQ Trademark

Trademark Overview


On Monday, January 17, 2022, a trademark application was filed for CORRECTSEQ with the United States Patent and Trademark Office. The USPTO has given the CORRECTSEQ trademark a serial number of 97222603. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, July 19, 2024. This trademark is owned by CorrectSequence Therapeutics Co., Ltd. The CORRECTSEQ trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for use in the treatment of diseases caused by point mutations; Drugs being pharmaceutical preparations for medical purposes for the treatment of diseases caused by point mutations; Stimulants for the central nervous system; Vaccines; Preparations of microorganisms for medical or veterinary use; Cultures of microorganisms for medical and veterinary use; Biological tissue cultures for medical purposes; Diagnostic biomarker reagents for medical purposes; Implants comprising living tissues for transplants; Reagents for medical genetic testing; Stem cells for medical purposes; Pharmaceutical preparations acting on the central nervous system

Biological research and analysis; Scientific research in the nature of conducting research and clinical trials for others; Genetic testing for scientific research purposes; Biomedical Research Services; Medical Research Services; Development of pharmaceutical preparations and medicines; Drug Research Services being pharmaceutical research; Structural and functional analysis of genomes
correctseq

General Information


Serial Number97222603
Word MarkCORRECTSEQ
Filing DateMonday, January 17, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, July 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in the treatment of diseases caused by point mutations; Drugs being pharmaceutical preparations for medical purposes for the treatment of diseases caused by point mutations; Stimulants for the central nervous system; Vaccines; Preparations of microorganisms for medical or veterinary use; Cultures of microorganisms for medical and veterinary use; Biological tissue cultures for medical purposes; Diagnostic biomarker reagents for medical purposes; Implants comprising living tissues for transplants; Reagents for medical genetic testing; Stem cells for medical purposes; Pharmaceutical preparations acting on the central nervous system
Pseudo MarkCORRECT SEQUENCE
Goods and ServicesBiological research and analysis; Scientific research in the nature of conducting research and clinical trials for others; Genetic testing for scientific research purposes; Biomedical Research Services; Medical Research Services; Development of pharmaceutical preparations and medicines; Drug Research Services being pharmaceutical research; Structural and functional analysis of genomes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 21, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCorrectSequence Therapeutics Co., Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShanghai 200120
CN

Party NameCorrectSequence Therapeutics Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShanghai 200120
CN

Trademark Events


Event DateEvent Description
Friday, October 28, 2022NON-FINAL ACTION WRITTEN
Thursday, January 20, 2022NEW APPLICATION ENTERED
Friday, January 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 25, 2022ASSIGNED TO EXAMINER
Friday, October 28, 2022NON-FINAL ACTION E-MAILED
Friday, October 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 25, 2024SOU EXTENSION 1 FILED
Thursday, January 25, 2024SOU EXTENSION 1 GRANTED
Saturday, January 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 19, 2024SOU TEAS EXTENSION RECEIVED
Friday, July 19, 2024SOU EXTENSION 2 GRANTED
Friday, July 19, 2024SOU EXTENSION 2 FILED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT